Study Stopped
Not currently enrolling subjects.
Exercise and Cognitive Rehab in Older Cancer Survivors
E-Co
An Exercise and COgnitive Rehabilitation Intervention for Older Cancer Survivors (The E-Co Study)
1 other identifier
interventional
40
1 country
1
Brief Summary
The objective of the study is to evaluate the feasibility of a combined mobile health exercise and cognitive rehabilitation intervention and its effect on cognition in a single-arm pilot study that recruits cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started May 2023
Typical duration for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2022
CompletedFirst Posted
Study publicly available on registry
May 24, 2022
CompletedStudy Start
First participant enrolled
May 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
January 5, 2026
December 1, 2025
3.6 years
May 18, 2022
December 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of the intervention
Feasibility is defined based on adherence to the intervention components: 1) At least 70% of patients provide exercise data on 50% on the intervention days; and 2) At least 70% of patients attend at least 8/10 of the MAAT-G workshops.
Post-intervention at week 12
Secondary Outcomes (4)
Self-reported cognition
Baseline and post-intervention at week 12
Cambridge Neuropsychological Test Automated Battery (CANTAB)
Baseline and post-intervention at week 12
Controlled Oral Word Association (COWA)
Baseline and post-intervention at week 12
Hopkins Verbal Learning Test-Revised (HVLT-R)
Baseline and post-intervention at week 12
Study Arms (1)
E-Co
EXPERIMENTALThe E-Co intervention will integrate active components of a mobile health exercise intervention (GO-EXCAP) into a cognitive rehabilitation intervention (MAAT-G).
Interventions
The E-Co intervention will integrate active components of a mobile health exercise intervention (GO-EXCAP) into a cognitive rehabilitation intervention (MAAT-G).
Eligibility Criteria
You may qualify if:
- Age ≥60 years at the time of consent
- Have a diagnosis of any cancer
- Have completed curative intent treatments
- Patients on endocrine therapies are allowed to enroll
- Patients with hematologic malignancies after autologous or allogeneic stem cell transplant are allowed to enroll as long as they have completed curative-intent treatment
- Have concerns about memory or other thinking abilities following cancer treatment\*
- English speaking (because the interventions are available in English language only)
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-3
- No medical contraindications for exercise per oncologist#
- Able to walk 4 meters#
- Able to provide informed consent#
- (\*) Confirmed by asking the patient (#) Confirmed through eligibility confirmation with the patient's oncologist or their designee
You may not qualify if:
- Physical, psychological, or social impairments that would interfere with patient's ability to participate in the study or participate in the intervention, as determined by the PIs and oncology team.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Rochester
Rochester, New York, 14642, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kah Poh Loh
University of Rochester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor - Department of Medicine, Hematology/Oncology (SMD)
Study Record Dates
First Submitted
May 18, 2022
First Posted
May 24, 2022
Study Start
May 19, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
January 5, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- The data will be available for 7 years after study completion
De-identified data will be shared with other investigators if requested. Published papers will be made available in portable document format.